ForSight Robotics, an Israeli eye surgery robotics startup, has received $55 million in Series A funding. Previously, the startup raised $10 million in seed funding last year and the total funding secured by the company accounts for $67 million in both grants and investments.
The financing round was led by The Adani Group along with existing investors Eclipse Ventures (which invested in Decentriq) and Mithril Capital. New investors, including Provenio Capital, Precision Capital, Reiya Ventures, and the Ljungstrom family office participated in the round.
Focuses on clinical trials
ForSight Robotics intends to use the funds to accelerate the development of the ORYOM platform for clinical trials. The company is working on procedures for preventable ophthalmic diseases such as glaucoma, and retinal diseases that can benefit from the accuracy of advanced visualisation and a robotics platform.
Dr. Joseph Nathan, co-founder and Chief Business Officer of ForSight Robotics said, “With the advancement of computing power, AI, and miniature mechanics, better access to healthcare will be made possible. Our goal is to work with industries across different geographies in order to benefit as many vision-impaired patients as possible.”
“We are pleased to be able to advance our technology with this investment to bring robotics into the world of ophthalmic surgery to help millions of patients who have to wait unnecessarily for procedures while their eyesight deteriorates,” said ForSight Chief Executive Officer and Co-Founder Dr. Daniel Glozman, “Our goal is to democratise this highly sophisticated procedure, enabling patients around the world to easily access the treatment that can restore their vision.”
Reimagines eye surgery
ForSight Robotics was founded by Dr. Daniel Glozman, Dr. Joseph Nathan, and Prof. Moshe Shoham in Haifa, Israel in 2020. The company’s flagship robotic platform will increase accessibility to ophthalmic surgery procedures worldwide and ultimately transform the future of eye surgery.
With a strategic board of medical robot experts, ForSight Robotics eyes to bridge the worldwide gap in the accessibility to eye surgery, and help over one billion people who suffer from preventable vision impairment and eye diseases.
The ORYOM platform leverages cutting-edge technologies in microsurgical robotics, computer visualisation, and machine learning. The intuitive platform automates the complex subtleties of ophthalmic surgery to treat the diseases underlying preventable blindness. Their platform is 10 times more accurate than the human hand, delivering ultimate consistency, for extremely safe surgeries with optimal refractive outcomes and has thereby raised the bar for such procedures, especially in a time of staffing shortages.